Filter by
Filter by
Results
Filter by
Content type
Key content topics
Key audience
Top cancer treatments
Four-year outcomes from a prospective phase II clinical trial of moderately hypofractionated PT for localized prostate cancer.
04/06/2019
/
Publications
Published in the Red Journal, the researchers of Upenn and Groningen reported the clinical and patient-reported outcomes for patients with prostate cancer...